Intraperitoneal heparin ameliorates the systemic inflammatory response in PD patients.

@article{Sjland2005IntraperitonealHA,
  title={Intraperitoneal heparin ameliorates the systemic inflammatory response in PD patients.},
  author={Jonas Angel Sj\oland and R. J. S. Pedersen and J\orgen Jespersen and J\orgen Gram},
  journal={Nephron. Clinical practice},
  year={2005},
  volume={100 4},
  pages={c105-10}
}
BACKGROUND Patients with end-stage renal disease (ESRD) suffer from high mortality rates of cardiovascular diseases, conditions closely linked to the magnitude of their chronic low-grade inflammation. As heparins have been suggested to possess anti-inflammatory properties, we set out to investigate the impact of long-term treatment with intraperitoneal heparin on local and systemic inflammation in peritoneal dialysis (PD) patients. METHODS In a double-blinded cross-over study, 21 PD patients… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Citrate supplementation of PD fluid: effects on net ultrafiltration and clearance of small solutes in single dwells.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2009
View 2 Excerpts

Similar Papers

Loading similar papers…